Tyrosine kinase inhibitors can cause significant hypoglycemia in patients with diabetes on other antihyperglycemic medications. These patients should be monitored, and their medications adjusted accordingly.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364065 | PMC |
| http://dx.doi.org/10.1002/ccr3.2901 | DOI Listing |
Publication Analysis
Top Keywords
dasatinib-induced hypoglycemia
4
hypoglycemia patient
4
patient acute
4
acute lymphoblastic
4
lymphoblastic leukemia
4
leukemia tyrosine
4
tyrosine kinase
4
kinase inhibitors
4
inhibitors hypoglycemia
4
hypoglycemia patients
4
Similar Publications
Tyrosine kinase inhibitors can cause significant hypoglycemia in patients with diabetes on other antihyperglycemic medications. These patients should be monitored, and their medications adjusted accordingly.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!